Success Metrics

Clinical Success Rate

100.0%

Based on 4 completed trials

Completion Rate

100%(4/4)

Active Trials

0(0%)

Results Posted

50%(2 trials)

Phase Distribution

Ph not_applicable

80%

Ph phase_1

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 1Safety & dosage

1(20.0%)

N/ANon-phased studies

4(80.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(4)

Terminated(1)

Detailed Status

Completed4

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 1

Trials by Phase

Phase 11 (20.0%)

N/A4 (80.0%)

Trials by Status

withdrawn120%

completed480%

Recent Activity

0 active trials

Showing 5 of 5

completednot_applicable

Efficacy of ARISTA-AH for Restoring Hemostasis Following Posterior Long-segment Spinal Fusion.

NCT05323448

completedphase_1

Clinical Trials (5)

Showing 5 of 5 trials

NCT05323448Not Applicable

Efficacy of ARISTA-AH for Restoring Hemostasis Following Posterior Long-segment Spinal Fusion.

Completed

NCT05522153Phase 1

Arista Hemostatic Powder for Total Knee Post Operative Outcomes Study

Completed

NCT02477774Not Applicable

Arista for ALT Donor Sites to Reduce Drain Output

Completed

NCT02568085Not Applicable

Trial Evaluating Use of Arista in Total Thyroidectomy

Withdrawn

NCT03068728Not Applicable

Analysis of Hemostatic Agents Compared to Physiologic Hemostasis

Completed

All 5 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 5